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Abstract 
Background: Multidrug-resistant strains of Acinetobacter baumannii have been reported increasingly around the world. The administration of 
an association of antibiotics has been proposed to create an active combination and to prevent the emergence of resistance. 
Methodology: The activity of colistin, rifampicin, gentamicin, imipenem and their associations was evaluated by means of killing curves in 
fourteen isolates belonging to three endemic PFGE types, in a university hospital of Buenos Aires city. The 14 isolates were selected on the 
basis of different mechanisms responsible for resistance to carbapenems and different susceptibility to colistin. 
Results: The mechanism responsible for the resistance to imipenem was the production of OXA-23 and OXA-58 carbapenemases. 
Heteroresistance to colistin was observed in six isolates. The associations colistin-rifampicin and colistin-imipenem were synergistic in 
heteroresistant isolates and prevented the development of colistin-resistant mutants. The association imipenem-gentamicin was bactericidal in 
gentamicin susceptible isolates, whereas the association imipenem-rifampicin was always indifferent. 
Conclusion: The antimicrobial activity and the presence of synergy are related to the antimicrobials’ susceptibilities irrespective of the PFGE 
type or the OXA-carbapenemase produced. 
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Introduction 
Acinetobacter baumannii (A. baumannii) is an 
important opportunistic pathogen, particularly for 
patients admitted to intensive care units (ICUs); 
hospital outbreaks caused by this organism have 
increased worldwide [1-2]. The emergence of A. 
baumannii clinical isolates with resistance to multiple 
antimicrobials, including broad-spectrum beta (ß)-
lactams, carbapenems, aminoglycosides, and 
fluroquinolones was observed. Carbapenem 
resistance has been correlated mainly with the 
acquisition of carbapenem hydrolysing class D ß-
lactamases [1]. Heteroresistance to colistin has been 
recently described by Li et al. [3].  
In Argentinian hospitals, the dissemination of 
strains which showed epidemic behaviour and were 
producers of OXA-23 and OXA-58 carbapenemases 
has been previously documented [4-5]. For the last 15 
years, our hospital has suffered a sustained endemia 
of multiresistant A. baumannii infections. The 
pathogen became carbapenem resistant in 1995 and 
since then, most of the strains have showed 
susceptibility to colistin and minocycline [6]. 
Management of A. baumannii multiresistant infection 
is a medical concern because of the limited 
therapeutic options available. The administration of 
an association of antibiotics has been proposed to 
create an active combination and to prevent the 
emergence of resistance [1].  
The aim of the present study was to investigate in 
a university hospital of Buenos Aires city, Argentina, 
the activity of imipenem (IMI), colistin (COL), 
rifampicin (RIF) and gentamicin (GEN) alone and in 
double combinations against fourteen multidrug 
resistant A. baumannii isolates, producers of OXA-23 
and OXA-58 carbapenemases with a high percentage 
of colistin heteroresistance. 
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Materials and methods 
Fourteen clinical isolates of multidrug-resistant 
(MDR) A. baumannii were collected from routine 
clinical samples of patients admitted to the intensive 
care unit (ICU) during the period June to December 
2004. Strains were identified by phenotypic tests and 
genomic species was determined by Amplified 
ribosomal DNA restriction analysis (ARDRA) [7]. 
Pulsed-field electrophoresis (PFGE) was performed 
with ApaI as described previously [8]. Minimal 
inhibitory concentrations (MICs) to COL (against the 
resistant subpopulations and the original strains), 
RIF, GEN and IMI were performed by agar dilution 
method and interpreted according to the Clinical and 
Laboratory Standards Institute (CLSI) [9] and Societe 
Française de Microbiologie for colistin and 
rifampicin [10]. Antibiotic powders were obtained 
from their respective manufacturers (COL, RIF, 
GEN: Sigma Chemical Co, USA; and IMI: Merck, 
Sharp & Dohme, Argentina). The activities of 
colistin, rifampicin, gentamicin, imipenem and their 
associations were evaluated by killing curves. The 
following concentrations were used: colistin 2 mg / 
liter; rifampicin 4 mg / liter; imipenem 8 mg / liter; 
gentamicin 4 mg / liter. Briefly, tubes containing 
cation-supplemented Mueller-Hinton broth (Lab. 
Britania) with and without antibiotic were inoculated 
with A. baumannii strains in a log-phase inoculum of 
roughly 5x 10
5
 CFU / ml. Tubes were incubated in an 
ambient atmosphere at 35 ºC. At time 0, 4 and 24 
hours after inoculation, serial 10-fold dilutions were 
performed and aliquots were plated onto nutrient 
agar. The time-kill studies were performed twice and 
results were analyzed by using mean colony count 
values from the duplicate plates for each isolate. The 
bactericidal activity of single antibiotics or 
combinations was defined as a ≥ 3-log10 CFU / ml 
decrease in the viable count compared with the initial 
inoculum. Synergism and antagonism were 
respectively defined as ≥ 2-log10 CFU / ml decrease 
or increase in the viable count with the combination 
compared with the most active agent alone at 
different time points. The presence of OXA 
carbapenemases was searched in the fourteen 
selected strains by PCR assays using previously 
described primer pairs for the blaoxa23, blaoxa58, blaoxa 40  
and blaoxa51-like, representative of the four OXA 
clusters [11]. Phenotypic screening test for metallo- ß-
lactamase production using sodium mercaptoacetic 
acid disks was also conducted [12]. 
 
 
Results 
Three different PFGE types were delineated in 
the 14 A. baumannii isolates. These PFGE types were 
identified as I, III, and IV, maintaining a previous 
nomenclature [4]. 
Twelve isolates were resistant to imipenem and 
only one to colistin. Rifampicin showed a high level 
of resistance in the majority of the isolates belonging 
to PFGE type I and a low level in PFGE types III and 
IV. All isolates belonging to PFGE type III and only 
one belonging to PFGE type IV were susceptible to 
gentamicin (Table 1). None of the isolates showed 
synergy in presence of sodium mercaptoacetic acid; 
thus they were presumed not to possess metallo- ß-
lactamases [12].  
In respect to the PCR results for the 
                         
PFGE  
types  
N   MIC CHDL Average   changes  referring to  the original  inoculum 
  ( µg/ml)       in log10  CFU/ml    
  IMI RIF GEN  IMI  RIF  GEN  IMI-RIF  IMI-GEN 
      4 hs.          24hs.  4 hs.            24hs.  4 hs        24 hs  4hs          24 hs  4 hs        24 hs 
I 6 32 >128 16 23 +1,2            +2,1  +1,4               +2,4  +1,0         +3,5  +1,2          +2,5  +0,5           +3,1 
I 1 0,5 2 >16  -2                -3,5  -2,0                -3,0  NA  -2,9           -3,8  
               
III 3 32 8 0,5 58 +1,1            +2,0  +2,0               +2,1  -1,0           -2,3  +1,0           +1,1  -1,0             -3,1 
               
IV 2 32 8 >16 23   0              +2,0  +1,1               +1,1  -0,7           -1,0  +1,1             0  -0,7             -1,8 
               
IV 1 64 8 2 23   0              +1,6  0                     -1,1  -1,0           -1,9  +1,2           -0,1  -1,0             -4,0 
               
IV 1 1 2 >16   -1,0          -4,0  -1,0              -3,9  NA              NA   -1,0           -3,9  
Table 1.  Pharmacodynamic effects of imipenem, rifampicin and gentamicin against A. baumannii endemic PFGE 
type producers of OXA-23 and OXA-58.  
 
N: Number of isolates studied; CHDL: Carbapenem-hydrolysing Class D oxacillinase; NA: not assessed. 
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carbapenemases, the bla oxa 51-like ß-lactamase gene 
was detected in all fourteen strains whereas blaoxa23 
was detected in carbapenem-resistant isolates in 
PFGE type I and IV and bla oxa58 in PFGE type III 
(Table 1).  
Heteroresistance to colistin was observed in six 
isolates (Table 2). 
 
Discussion 
In the present study the concentrations for the 
time-kill experiments were selected according to the 
serum-levels and the breakpoints established by 
CLSI, because we believe that these concentrations 
show better correlations with therapeutic conditions 
than MIC multiples in MDR strains [13-14]. 
In time-kill studies, imipenem showed 
bactericidal activity against only two carbapenem-
susceptible strains, confirming its excellent activity. 
We observed bacteriostatic activity at four hours in 
all the IMI resistant strains irrespective of PFGE type 
or production of acquired Class D carbapenemases 
(Table 1). Similar results were reported by Tripodi et 
al. but we believe that this behaviour would not have 
clinical relevance and that it would be related to the 
heteroresistance to carbapenems [15].  
Colistin sulphate showed bactericidal activity 
before 4 hs of incubation in non-heteroresistant 
isolates. In heteroresistant isolates we observed a 
decrease in the bactericidal activity or regrowth of 
resistant sub-populations (MIC 4-fold higher than in 
original strains) at 24 hours of incubation. 
Bacteriostatic activity was detected in the resistant 
isolate (Table 2). We demonstrated bactericidal 
activity with GEN in isolates belonging to PFGE type 
III and in one isolate in PFGE type IV if they were 
susceptible to GEN and showed synergy when 
combined with IMI (Table 1). The GEN 
concentration used is the one achieved in serum and 
lung tissue; hence this antimicrobial association 
could be a possible therapeutic option for the 
treatment of these MDR isolates.  
In A. baumannii infections, RIF has been used in 
combinations with other antimicrobials to prevent the 
emergence of resistant mutants. Three rifampicin 
MIC values were obtained: 2, 8, and > 128 ug /ml. 
Bactericidal activity was detected only in the isolate 
with an MIC of 2 ug /ml. The association IMI-RIF 
did not show ability to achieve synergy in isolates 
harbouring OXA-23 or OXA-58, because the RIF 
concentrations used were always lower than the MIC 
value (sub-MIC) (Table 1). Tripodi et al. reported 
synergy with the combination IMI-RIF against 
producers of OXA-58 isolates using RIF 
concentrations higher than the MIC value in killing 
curves [15]. However, we observed that RIF plus 
COL showed synergy by inhibition of resistant sub-
populations in heteroresistant isolates irrespective of 
the RIF MIC values and we detected synergy at 24 
hours in the isolate resistant to COL despite its high 
MIC to both antimicrobials (Table 2). Similarly, the 
combination COL plus RIF was constantly 
synergistic against S. marcescens, an organism that is 
intrinsically resistant to polimixyns [16].  
In non heteroresistant isolates we were unable to 
demonstrate synergy between COL and IMI in 
isolates harbouring OXA-23 or OXA-58, partly 
because COL alone showed a rapid initial 
bactericidal effect (before four hours of incubation). 
PFGE 
 types   N CHDL S. col
1 
MIC COL   Average changes  
 
referring to the original  
 
inoculum   
   
 
( µg/ml)         (log10CFU/ml )   
   
 
       COL     COL-RIF    COL-IMI 
      4 hs             24hs  4hs              24hs  4hs           24hs 
I 3 23 H
2
 1  -0,5               -3,5  -4,0                -4,0  -4               -3,9 
 3 23* no H
3 
1  -2,9               -3,9  -3,0                -3,9  -4               -3,9 
 1 23 R
4 
32  -1,8               -1,5  +1,2               -2,9  -2,2            -3,0 
           
III 3 58 H 1  -1,8               +1,1  -2,0                -3,9  -1,9             -4,0 
           
IV 4 23** no H 1  -3,9               -4,1  -3,8                -4,0  -3,9             -3,9 
x
x
x
 
Table 2. Pharmacodynamic effects of colistin and colistin plus rifampicin or imipenem against A. baumannii resistant, 
heteroresistant or non-heteroresistant isolates. 
1: Susceptibilities of colistin; 2: Heteroresistant isolates; 3: non-heteroresistant isolates; 4: resistant isolates, N: Number of isolates studied. CHDL: Carbapenem-hydrolysing Class D oxacillinase, * only 
in two strains, **in three strains. 
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As it was previously mentioned, in heteroresistant 
isolates both COL-RIF and COL-IMI combinations 
were synergistic in inhibition of regrowth (Table 2). 
Similar findings were obtained with the colistin–
minocycline associations [17]. Few synergy studies 
have been conducted in A. baumannii COL resistant 
strains. In agreement with a previous report by Yoon 
et al. [13], we detected bactericidal activity between 
IMI-COL or COL-RIF at 4 and 24 hours, respectively 
(Table 2). The rapid permeabilization of the outer 
membrane would enhance the action of the other 
antimicrobials in COL susceptible strains, whereas 
the synergistic mechanism in COL resistant isolates 
remains unknown. In accordance with Principe et al., 
we observed different intraclonal synergistic 
activities that reflect the complex interactions of 
multiple mechanisms of antimicrobial resistance in A. 
baumannii [18]. 
In conclusion, these studied strains belong to the 
three major endemic PFGE types in Buenos Aires 
city [4]. Thus, our results could be applied in our 
hospital and other medical centers for the treatment 
of multiresistant A. baumannii infections. From our 
data, we showed that the combination of COL plus 
RIF or IMI was effective (always bactericidal and 
synergistic against heteroresistant isolates) and it 
prevented the selection of resistance. In this study we 
demonstrated that the antimicrobial activity and the 
presence of synergy are related to the antimicrobials’ 
susceptibilities irrespective of the PFGE types or the 
OXA-carbapenemase produced. 
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